News

Topspin Fund, an investment group of James Simons, Leo Guthart and Steve Winick, led the financing, which also includes the participation of existing investors Aisling Capital, OrbiMed Advisors

Jentadueto helps patients to control their blood sugar. It can be taken twice daily and combines two diabetes medicines – the dipeptidyl peptidase-4 (DPP-4) inhibitor, linagliptin and metformin

This study is the first Phase III trial to demonstrate the efficacy of a medical therapy for Cushing’s disease, which is a debilitating endocrine disorder caused by excess

APX004 is a humanized monoclonal antibody directed against VEGFR2 for the treatment of certain cancers and angiogenic diseases. As per the agreement, GDBP will have an exclusive license

AIT, a dissolvable oral tablet is being studied to determine whether AIT may help to prevent allergy symptoms by stimulating an immune response against targeted allergens. Phase III

The new production line will produce Paclitaxel, a chemotherapy agent inhibiting proliferation of cancer cells used in the treatment of patients with breast, ovarian and non-small cell lung

The calcium in Xtra-Cal helps maintain strong, healthy bones and teeth while the magnesium and vitamin D present in the product enable improved calcium absorption. Xtra-Cal consumption will

According to the study data, 74% (28 out of 38) of patients who were treated with Incivek combination therapy had undetectable hepatitis C virus (HCV RNA) 12 weeks

Surfaxin (lucinactant intratracheal suspension) is a synthetic, peptide-containing surfactant, indicated for use in premature infants at high risk for RDS. Discovery Labs chief executive officer and chairman of